References

1. Hyland CA et al. Three unrelated Rh D gene polymorphisms identified among blood donors with Rhesus CCee (r'r') phenotypes. Blood, 1994. [Citation] [RHeference]
2. Noizat-Pirenne F et al. Molecular analysis of selected Rh variants. Transfus Clin Biol, 1996. [Citation] [RHeference]
3. Chérif-Zahar B et al. Shift from Rh-positive to Rh-negative phenotype caused by a somatic mutation within the RHD gene in a patient with chronic myelocytic leukaemia. Br J Haematol, 1998. [Citation] [RHeference]
4. Andrews KT et al. The RhD- trait in a white patient with the RhCCee phenotype attributed to a four-nucleotide deletion in the RHD gene. Blood, 1998. [Citation] [RHeference]
5. Reid ME et al. Two examples of an inseparable antibody that reacts equally well with DW+ and Rh32+ red blood cells. Vox Sang, 1998. [Citation] [RHeference]
6. Cowley NM et al. RHD gene mutations and the weak D phenotype: an Australian blood donor study. Vox Sang, 2000. [Citation] [RHeference]
7. Noizat-Pirenne F et al. Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood, 2002. [Citation] [RHeference]
8. Peng CT et al. Molecular basis for the RhD negative phenotype in Chinese. Int J Mol Med, 2003. [Citation] [RHeference]
9. Reid ME et al. DAK, a new low-incidence antigen in the Rh blood group system. Transfusion, 2003. [Citation] [RHeference]
10. Noizat-Pirenne F et al. Serological studies of monoclonal RH antibodies with RH1 (D), RH2 (C), RH3 (E) and RH5 (e) variant RBCs. Transfus Clin Biol, 2003. [Citation] [RHeference]
11. Ansart-Pirenne H et al. RhD variants in Caucasians: consequences for checking clinically relevant alleles. Transfusion, 2004. [Citation] [RHeference]
12. Körmöczi GF et al. Molecular and serologic characterization of DWI, a novel "high-grade" partial D. Transfusion, 2004. [Citation] [RHeference]
13. Doescher A et al. Weak D type 1.1 exemplifies another complexity in weak D genotyping. Transfusion, 2005. [Citation] [RHeference]
14. Luettringhaus TA et al. An easy RHD genotyping strategy for D- East Asian persons applied to Korean blood donors. Transfusion, 2006. [Citation] [RHeference]
15. Flegel WA et al. In-frame triplet deletions in RHD alter the D antigen phenotype. Transfusion, 2006. [Citation] [RHeference]
16. Araújo F et al. Weak D type 2 is the most prevalent weak D type in Portugal. Transfus Med, 2006. [Citation] [RHeference]
17. Richard M et al. A new DEL variant caused by exon 8 deletion. Transfusion, 2007. [Citation] [RHeference]
18. Vaglio S et al. Anti-D in a D-positive patient: autoantibody or alloantibody? Blood Transfus, 2007. [Citation] [RHeference]
19. Pham BN et al. Heterogeneous molecular background of the weak C, VS+, hr B-, Hr B- phenotype in black persons. Transfusion, 2009. [Citation] [RHeference]
20. Pham BN et al. Anti-D investigations in individuals expressing weak D Type 1 or weak D Type 2: allo- or autoantibodies? Transfusion, 2011. [Citation] [RHeference]
21. Krog GR et al. Is current serologic RhD typing of blood donors sufficient for avoiding immunization of recipients? Transfusion, 2011. [Citation] [RHeference]
22. Szulman A et al. Investigation of pseudogenes RHDΨ and RHD-CE-D hybrid gene in D-negative blood donors by the real time PCR method. Transfus Apher Sci, 2012. [Citation] [RHeference]
23. M E Reid et al. DIVa and DIVa-2 are Encoded by the Same RHD Allele Transfusion, 2012. — Abstract — [RHeference]
24. Fichou Y et al. Weak D caused by a founder deletion in the RHD gene. Transfusion, 2012. [Citation] [RHeference]
25. Silvy M et al. Characterization of novel RHD alleles: relationship between phenotype, genotype, and trimeric architecture. Transfusion, 2012. [Citation] [RHeference]
26. Lejon Crottet S et al. Serologic and molecular investigations of DAR1 (weak D Type 4.2), DAR1.2, DAR1.3, DAR2 (DARE), and DARA. Transfusion, 2013. [Citation] [RHeference]
27. Roussel M et al. RHD*DOL1 and RHD*DOL2 encode a partial D antigen and are in cis with the rare RHCE*ceBI allele in people of African descent. Transfusion, 2013. [Citation] [RHeference]
28. Gassner C et al. Novel RHD alleles with weak hemagglutination and genetic Exon 9 diversity: weak D Types 45.1, 75, and 76. Transfusion, 2013. [Citation] [RHeference]
29. Fichou Y et al. Establishment of a medium-throughput approach for the genotyping of RHD variants and report of nine novel rare alleles. Transfusion, 2013. [Citation] [RHeference]
30. Pham BN et al. Molecular analysis of patients with weak D and serologic analysis of those with anti-D (excluding type 1 and type 2). Immunohematology, 2013. [Citation] [RHeference]
31. Arnoni CP et al. How do we identify RHD variants using a practical molecular approach? Transfusion, 2014. [Citation] [RHeference]
32. Kappler-Gratias S et al. Systematic RH genotyping and variant identification in French donors of African origin. Blood Transfus, 2014. [Citation] [RHeference]
33. Gowland P et al. Molecular RHD screening of RhD negative donors can replace standard serological testing for RhD negative donors. Transfus Apher Sci, 2014. [Citation] [RHeference]
34. Crottet SL et al. Implementation of a mandatory donor RHD screening in Switzerland. Transfus Apher Sci, 2014. [Citation] [RHeference]
35. A C Gaspardi et al. RHD variants in blood donors from Southeast Brazil. Transfusion, 2015. — Abstract — [RHeference]
36. Arnoni CP et al. Identification of four novel RHD alleles with altered expression of D in Brazilians. Transfusion, 2016. [Citation] [RHeference]
37. C Henny et al. Impact of the mandatory donor RHD screening in Switzerland Vox Sanguinis, 2016. — Abstract — [RHeference]
38. Raud L et al. From genetic variability to phenotypic expression of blood group systems. Transfus Clin Biol, 2017. [Citation] [RHeference]
39. Fennell K et al. Effect on gene expression of three allelic variants in GATA motifs of ABO, RHD, and RHCE regulatory elements. Transfusion, 2017. [Citation] [RHeference]
40. Bruno Costes et al. c.1154-31C>T Is in Linkage Disequilibrium with the Missense Mutation C.1154G>C on RHD Weak Type 2 Transfusion, 2017. — Abstract — [RHeference]
41. Floch A et al. Molecular characterization of 13 new RHD alleles. Transfusion, 2017. [Citation] [RHeference]
42. Jérôme Babinet et al. Inscription des individus RH : −1, −4 ou RH : −1, −5 dans le registre national de référence des sujets présentant un phénotype/génotype érythrocytaire rare : intérêt de la réalisation d’une PCR multiplexe systématique pour le dépistage des variants RH1 affaiblis non détectés par sérologie de routine Transfusion Clinique et Biologique, 2017. — Abstract — [RHeference]
43. McGowan EC et al. Diverse and novel RHD variants in Australian blood donors with a weak D phenotype: implication for transfusion management. Vox Sang, 2017. [Citation] [RHeference]
44. Saleheen D et al. Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity. Nature, 2017. [Citation] [RHeference]
45. Turley E et al. Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31). Transfusion, 2018. [Citation] [RHeference]
46. C Vrignaud et al. A Novel RHCE Allele Expressing RHD Epitopes Responsible for a False-Positive D Typing and Post-Transfusion Anti-D Alloimmunization in a Patient of Western European Descent Transfusion, 2018. — Abstract — [RHeference]
47. V L. Thonier et al. Complex Antibody Mixture in a Pregnant Woman Harboring the RHD*DIIIb Variant Allele Transfusion, 2018. — Abstract — [RHeference]
48. C Araujo et al. Serological and Molecular Characterization of Weak D Type 18 in Four Brazilian Families Transfusion, 2018. — Abstract — [RHeference]
49. Jérôme Babinet et al. Erratum à l’article : « Résumés des Posters » [Transfus. Clin. Biol. 24 (2017) 3S] Transfusion Clinique et Biologique, 2018. — Abstract — [RHeference]
50. Aparecida de Paula Vendrame T et al. Molecular characterization of three novel RHD alleles in Brazilians. Transfusion, 2018. [Citation] [RHeference]
51. de Brevern AG et al. Alloimmunization risk associated with amino acid 223 substitution in the RhD protein: analysis in the light of molecular modeling. Transfusion, 2018. [Citation] [RHeference]
52. de Paula Vendrame TA et al. Characterization of RHD alleles present in serologically RHD-negative donors determined by a sensitive microplate technique. Vox Sang, 2019. [Citation] [RHeference]
53. L Castilho et al. From genotyping to the functional and clinical interpretation of variations in blood group genes by 3D-protein structure investigation: two novel variant alleles in the RHD gene Vox Sanguinis, 2019. — Abstract — [RHeference]
54. C von Arx et al. A novel RHD splice donor site mutation leading to a RhD-negative phenotype Vox Sanguinis, 2019. — Abstract — [RHeference]
55. Raud L et al. Weak D type 1, 2 and 3 subtype alleles are rare in the Western French population. Transfus Med, 2019. [Citation] [RHeference]
56. de Paula Vendrame TA et al. Novel RHD alleles in African Brazilians. Transfusion, 2019. [Citation] [RHeference]
57. Stettler J et al. Reduced RhD antigen expression caused by two novel RHD variant alleles. Transfusion, 2020. [Citation] [RHeference]
58. Aline Floch et al. Understanding anti-D formation in RhD variants through the study of 3D intraprotein interactions manuscript in preparation, 2020. — Article — [RHeference]
59. Thongbut J et al. Comprehensive Molecular Analysis of Serologically D-Negative and Weak/Partial D Phenotype in Thai Blood Donors. Transfus Med Hemother, 2020. [Citation] [RHeference]